Chan Zuckerberg Initiative - Footnote 71

Note: The claim that the organization's AI work focuses EXCLUSIVELY on biomedical applications is not supported by the source. The source mentions four 'grand challenges' with drug discovery implications, but does not state that these are the ONLY areas of focus. The claim mentions 'large-scale AI models for cell biology, virtual immune systems, and drug discovery.' The source mentions 'Developing a unified AI model of the cell to predict cellular behaviour,' 'launching the Virtual Immune System,' and that the grand challenges have 'significant implications for drug discovery.' The claim is a reasonable summary of these points, but it is not a direct quote or explicit statement from the source.